Gut microbiota and immune crosstalk in metabolic disease
Background: Gut microbiota is considered as a major regulator of metabolic disease. This reconciles the notion of metabolic inflammation and the epidemic development of the disease. In addition to evidence showing that a specific gut microbiota characterizes patients with obesity, type 2 diabetes, a...
Saved in:
Main Author: | Rémy Burcelin (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2016-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gut Microbiota-Immune System Crosstalk and Pancreatic Disorders
by: D. Pagliari, et al.
Published: (2018) -
Crosstalk between vitamin status and gut microbiota: The key to maintaining immune homeostasis in the gut
by: Rakić Marija, et al.
Published: (2023) -
The Microbiota and Immune System Crosstalk in Health and Disease
by: Rossella Cianci, et al.
Published: (2018) -
Targeting gut microbiota and immune crosstalk: potential mechanisms of natural products in the treatment of atherosclerosis
by: Jinpeng Jing, et al.
Published: (2023) -
Crosstalk Between Polygonatum kingianum, the miRNA, and Gut Microbiota in the Regulation of Lipid Metabolism
by: Jincai Dong, et al.
Published: (2021)